Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.74 -9.63 (-3.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Shares Outstanding (Entity) (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Shares Outstanding (Entity) of 19.92 million in Q2 2026, up 2.6% from 19.41 million a year earlier but down 0.5% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

For FY2025, Ligand Pharmaceuticals reported Shares Outstanding (Entity) of 19.77 million, up 3.5% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for five straight years, with a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 19.11 million in FY2024 (+8.8%), 17.56 million in FY2023 (+3.6%), 16.95 million in FY2022 (+1.1%) and 16.77 million in FY2021 (+4.3%).
  • Quarterly Shares Outstanding (Entity) has ranged from 16.71 million in Q3 2021 to 20.03 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 22 consecutive quarters, with growth averaging 5.8% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.1% in Q4 2022 to 8.8% in Q4 2024.
  • Per Business Quant, the preceding three quarters came in at 20.03 million (Q1 2026), 19.77 million (Q4 2025) and 19.66 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 19.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.92 Mn
Mar 31, 2026 20.03 Mn
Dec 31, 2025 19.77 Mn
Sep 30, 2025 19.66 Mn
Jun 30, 2025 19.41 Mn
Mar 31, 2025 19.28 Mn
Dec 31, 2024 19.11 Mn
Sep 30, 2024 18.76 Mn
Jun 30, 2024 18.10 Mn
Mar 31, 2024 17.92 Mn
Dec 31, 2023 17.56 Mn
Sep 30, 2023 17.42 Mn
Jun 30, 2023 17.35 Mn
Mar 31, 2023 17.13 Mn
Dec 31, 2022 16.95 Mn
Sep 30, 2022 16.89 Mn
Jun 30, 2022 16.88 Mn
Mar 31, 2022 16.86 Mn
Dec 31, 2021 16.77 Mn
Sep 30, 2021 16.71 Mn
API Access

Ligand Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LGND&period=max&api_key=YOUR_API_KEY